ATE353670T1 - Dns pferdeimpfstoffe adjuviert mit acryl- oder methacrylpolymersäuren oder ema (r) - Google Patents

Dns pferdeimpfstoffe adjuviert mit acryl- oder methacrylpolymersäuren oder ema (r)

Info

Publication number
ATE353670T1
ATE353670T1 AT99909069T AT99909069T ATE353670T1 AT E353670 T1 ATE353670 T1 AT E353670T1 AT 99909069 T AT99909069 T AT 99909069T AT 99909069 T AT99909069 T AT 99909069T AT E353670 T1 ATE353670 T1 AT E353670T1
Authority
AT
Austria
Prior art keywords
adjuvated
ema
dna
acrylic
polymer acids
Prior art date
Application number
AT99909069T
Other languages
English (en)
Inventor
Jean-Christophe Franc Audonnet
Jules Maarten Minke
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9525029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE353670(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of ATE353670T1 publication Critical patent/ATE353670T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99909069T 1998-04-03 1999-03-22 Dns pferdeimpfstoffe adjuviert mit acryl- oder methacrylpolymersäuren oder ema (r) ATE353670T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9804409A FR2776928B1 (fr) 1998-04-03 1998-04-03 Vaccins adn adjuves

Publications (1)

Publication Number Publication Date
ATE353670T1 true ATE353670T1 (de) 2007-03-15

Family

ID=9525029

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99909069T ATE353670T1 (de) 1998-04-03 1999-03-22 Dns pferdeimpfstoffe adjuviert mit acryl- oder methacrylpolymersäuren oder ema (r)

Country Status (17)

Country Link
US (1) US7163926B1 (de)
EP (1) EP1066055B1 (de)
JP (1) JP2002510651A (de)
AR (1) AR037062A1 (de)
AT (1) ATE353670T1 (de)
AU (1) AU744964B2 (de)
BR (1) BR9909342A (de)
CA (1) CA2327389C (de)
CY (1) CY1108013T1 (de)
DE (1) DE69935136T2 (de)
DK (1) DK1066055T3 (de)
ES (1) ES2283105T3 (de)
FR (1) FR2776928B1 (de)
PL (1) PL194348B1 (de)
PT (1) PT1066055E (de)
WO (1) WO1999051269A1 (de)
ZA (1) ZA992478B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804026B1 (fr) * 2000-01-21 2004-06-11 Merial Sas Vaccination contre l'herpesvirose canine et vaccins
US6551598B2 (en) 2000-01-21 2003-04-22 Merial Vaccination against canine herpesvirosis and vaccines therefor
CN1638780A (zh) * 2001-12-14 2005-07-13 遗传电子公司 用脉冲电场进行颗粒辅助的多核苷酸免疫的方法
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
UA100370C2 (uk) 2006-12-11 2012-12-25 Мериал Лимитед Спосіб вакцинації птахів проти salmonella
CL2008001806A1 (es) * 2007-06-20 2008-09-05 Wyeth Corp Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
GB0805356D0 (en) * 2008-03-25 2008-04-30 Isis Innovation Vaccine adjuvant composition
CN102066411A (zh) 2008-05-08 2011-05-18 梅里亚有限公司 使用白蛉唾液免疫原的利什曼原虫疫苗
US8168200B2 (en) * 2008-10-24 2012-05-01 Merial Limited Vaccine against african horse sickness virus
TR201901466T4 (tr) 2011-07-20 2019-02-21 Centre Nat Rech Scient Opti̇mi̇ze edi̇lmi̇ş feli̇n lösemi̇ vi̇rüsü zarf geni̇ni̇ i̇çeren rekombi̇nant feli̇n lösemi̇ vi̇rüsü
WO2013106558A1 (en) 2012-01-10 2013-07-18 Merial Limited Lipid based adjuvants for dna - plasmid vaccines
BR112014023414B1 (pt) 2012-03-20 2022-08-30 Boehringer Ingelheim Animal Health USA Inc. Vacina de herpesvirus-1 equino recombinante contendo uma glicoproteína c mutante e seus usos
CN104768577B (zh) 2012-08-30 2020-06-09 梅里亚有限公司 高压设备和用于制备灭活疫苗和用于重折叠/增溶重组蛋白的方法
WO2016210097A1 (en) * 2015-06-23 2016-12-29 The Trustees Of Columbia University In The City Of New York Novel equine parvovirus and uses thereof
DK3471760T3 (da) 2016-06-17 2025-01-27 Boehringer Ingelheim Vetmedica Gmbh Hidtil ukendte immunogene formuleringer, der omfatter lineære eller forgrenede polyacrylsyrepolymeradjuvanser
CN115836042A (zh) * 2020-07-07 2023-03-21 阿米瑞斯公司 疫苗佐剂及其合成和使用方法
CN114272368A (zh) * 2021-12-16 2022-04-05 成都博宠生物科技有限公司 一种猪瘟和猪伪狂犬二联疫苗及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920811A (en) * 1972-12-22 1975-11-18 Cutter Lab Adjuvant compositions
CA1267087A (en) * 1985-02-14 1990-03-27 Nicolaas Visser Synthetic immunogen
EP0283085B1 (de) * 1987-03-17 1992-11-11 Akzo N.V. Adjuvanzienmischung
US6004563A (en) * 1990-11-07 1999-12-21 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
EP0532833A1 (de) * 1991-05-28 1993-03-24 Miles Inc. Pferde-Rhinopneumonitis Impfstoff
DE69333416D1 (de) * 1992-06-01 2004-03-18 Univ Melbourne Parkville Immunologisches Verfahren für die Detektion von Pferde-Herpesvirus Typ 1 und 4 glycoprotein G Antikörper
AU5543294A (en) * 1993-10-29 1995-05-22 Pharmos Corp. Submicron emulsions as vaccine adjuvants
BE1008977A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US6300118B1 (en) * 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
FR2751226B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies du cheval
GB9623051D0 (en) * 1996-11-06 1997-01-08 Schacht Etienne H Delivery of DNA to target cells in biological systems
US6406705B1 (en) * 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
EP0991767A1 (de) * 1997-06-11 2000-04-12 Institut Pasteur Abgeschwächte rekombinante mycobacterien, die immunogene oder als impfstoff nützlich sind
WO1999004009A1 (en) * 1997-07-14 1999-01-28 Wisconsin Alumni Research Foundation Method of dna vaccination using dna encoding antigen and encoding il6
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
US6444799B1 (en) * 1997-12-31 2002-09-03 Csl Limited P. gingivalis polynucleotides and uses thereof

Also Published As

Publication number Publication date
EP1066055B1 (de) 2007-02-14
PL343602A1 (en) 2001-08-27
DE69935136D1 (de) 2007-03-29
CY1108013T1 (el) 2013-09-04
CA2327389C (en) 2011-06-14
US7163926B1 (en) 2007-01-16
JP2002510651A (ja) 2002-04-09
WO1999051269A1 (fr) 1999-10-14
AU2844899A (en) 1999-10-25
DE69935136T2 (de) 2007-11-29
DK1066055T3 (da) 2007-06-11
ZA992478B (en) 2000-10-10
AR037062A1 (es) 2004-10-20
ES2283105T3 (es) 2007-10-16
PT1066055E (pt) 2007-05-31
CA2327389A1 (en) 1999-10-14
BR9909342A (pt) 2000-12-12
EP1066055A1 (de) 2001-01-10
FR2776928B1 (fr) 2000-06-23
FR2776928A1 (fr) 1999-10-08
PL194348B1 (pl) 2007-05-31
AU744964B2 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
ATE353670T1 (de) Dns pferdeimpfstoffe adjuviert mit acryl- oder methacrylpolymersäuren oder ema (r)
DE69929099D1 (de) Gerät zur Extraktion von Nukleinsäuren
DE59807440D1 (de) Vorrichtung zur Wasserenthärtung
NO960408D0 (no) DNA sekvenseringsenzymer
DE69724863D1 (de) Vorrichtung zur Erkennung einer Herzarrhythmie
FI971611L (fi) DNA-polymeraaseja joilla on modifioitu nukleotidisitoutumiskohta DNA-sekvensointia varten
FI971176A0 (fi) DNA-fotopilkkominen käyttäen teksapyriinejä
ID20500A (id) Metoda untuk memperoleh asam akrilat
DE59813840D1 (de) Protein mit phospholipaseaktivität
DE60037048D1 (de) System zur Vermeidung von Heckberührung bei Flugzeugen
DK0877018T3 (da) Sulfonylaminocarboxylsyrer
DE69830758D1 (de) Verfahren zur Oberflächenbehandlung
DE69811802D1 (de) Verfahren zur Transesterification
DE69737231D1 (de) Impfung mit nukleinsäuren gegen parvovirus infektionen
DE69835676D1 (de) Dna polymerase-verwandte faktoren
DK94897A (da) Propeller
NO964628D0 (no) DNA-sekvenser
DE59707787D1 (de) Leuchtdiodenmatrix
DE69824448T2 (de) Graviersystem und -verfahren mit verschiedenen gravierwerkzeugen
DE69739700D1 (de) Sensormatrix
PT898969E (pt) Vacina de neospora
DE69728130D1 (de) Bodenanordnung zur Entgasung
DE59805294D1 (de) Fahnenmast mit Hissvorrichtung
DE69905187D1 (de) System zur erkennung von eindrücken
DE69508572D1 (de) Methode zur kultivierung von tierzellen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1066055

Country of ref document: EP